Mangoceuticals announces study on avian flu prevention in poultry using water-based antiviral solution

MANGOCEUTICALS, INC.

Engaged Vipragen Biosciences for efficacy studies on H5N1 prevention via drinking water solution.
Phase I animal studies showed significant reduction in lung viral load; Phase II ongoing.
Solution uses GRAS ingredients; aims to offer non-pharmaceutical preventive tool.
Avian flu outbreak led to culling of >148M birds in U.S. since 2022; egg prices hit $4.15/dozen Dec 2024.
Global poultry market projected at $375.41B by 2030; company to share final study results upon completion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.